About the Authors
- Ling-Zhi Wang
-
Affiliations Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore, Department of Pharmacology, National University of Singapore, Singapore, Singapore
- Jacqueline Ramírez
-
Affiliation Department of Medicine, The University of Chicago, Chicago, Illinois, United States of America
- Winnie Yeo
-
Affiliation Department of Clinical Oncology, Chinese University of Hong Kong, Hong Kong, China
- Mei-Yi Michelle Chan
-
Affiliation Department of Pharmacy, National University of Singapore, Singapore, Singapore
- Win-Lwin Thuya
-
Affiliation Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore
- Jie-Ying Amelia Lau
-
Affiliation Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore
- Seow-Ching Wan
-
Affiliation Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore
- Andrea Li-Ann Wong
-
Affiliation Department of Hematology & Oncology, National University Health System, Singapore, Singapore
- Ying-Kiat Zee
-
Affiliation Department of Hematology & Oncology, National University Health System, Singapore, Singapore
- Robert Lim
-
Affiliation Department of Hematology & Oncology, National University Health System, Singapore, Singapore
- Soo-Chin Lee
-
Affiliations Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore, Department of Hematology & Oncology, National University Health System, Singapore, Singapore
- Paul C. Ho
-
Affiliation Department of Pharmacy, National University of Singapore, Singapore, Singapore
- How-Sung Lee
-
Affiliation Department of Pharmacology, National University of Singapore, Singapore, Singapore
- Anthony Chan
-
Affiliation Department of Clinical Oncology, Chinese University of Hong Kong, Hong Kong, China
- Sherry Ansher
-
Affiliation Cancer Therapy Evaluation Program, Bethesda, Maryland, United States of America
- Mark J. Ratain
-
Affiliations Department of Medicine, The University of Chicago, Chicago, Illinois, United States of America, Committee on Clinical Pharmacology and Pharmacogenomics, The University of Chicago, Chicago, Illinois, United States of America, Comprehensive Cancer Center, The University of Chicago, Chicago, Illinois, United States of America
- Boon-Cher Goh
-
* E-mail: phcgbc@nus.edu.sg
Affiliations Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore, Department of Pharmacology, National University of Singapore, Singapore, Singapore, Department of Hematology & Oncology, National University Health System, Singapore, Singapore
Competing Interests
The authors have declared that no competing interests exist. Please note that belinostat is a Topotarget product. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: BCG LZW WY AC SA. Performed the experiments: LZW JR MYMC WLT JYAL SCW ALAW YKZ RL. Analyzed the data: BCG MJR LZW JR WY SCL PCH HSL AC ALAW YKZ RL. Contributed reagents/materials/analysis tools: WY MJR HSL PCH AC SA. Wrote the paper: BCG LZW MJR JR PCH HSL.